129 related articles for article (PubMed ID: 12665847)
1. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?
Rozman P; Karas M; Kosir A; Labar B; Madrigal A; Middleton D; Navarrete C; Oudshoorn M; Schennach H; Vitek A; Bohinjec M;
Bone Marrow Transplant; 2003 Mar; 31(6):497-506. PubMed ID: 12665847
[TBL] [Abstract][Full Text] [Related]
2. Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation.
Kotzampasaki EM; Spyropoulou-Vlachou MS; Kalofoutis C; Vrani V; Kalofoutis A; Stavropoulos-Giokas C
Transplant Proc; 2004; 36(6):1735-8. PubMed ID: 15350465
[TBL] [Abstract][Full Text] [Related]
3. The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimen.
Leitner GC; Stiegler G; Kalhs P; Greinix HT; Rabitsch W; Sillaber C; Hoecker P; Panzer S
Transfusion; 2005 Feb; 45(2):195-201. PubMed ID: 15660827
[TBL] [Abstract][Full Text] [Related]
4. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
5. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
6. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
7. Influence of human platelet antigen match on the success of stem cell transplantation after myeloablative conditioning.
Leitner GC; Tanzmann A; Stiegler G; Kalhs P; Greinix HT; Hoecker P; Panzer S
Bone Marrow Transplant; 2003 Oct; 32(8):821-4. PubMed ID: 14520428
[TBL] [Abstract][Full Text] [Related]
8. RE: Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation.
Brickner AG
Transplant Proc; 2005 Dec; 37(10):4640-1; author reply 4641. PubMed ID: 16387190
[No Abstract] [Full Text] [Related]
9. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients.
Murata M; Emi N; Hirabayashi N; Hamaguchi M; Goto S; Wakita A; Tanimoto M; Saito H; Kodera Y; Morishita Y;
Int J Hematol; 2000 Oct; 72(3):371-5. PubMed ID: 11185997
[TBL] [Abstract][Full Text] [Related]
10. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.
Martin PJ
Bone Marrow Transplant; 1991 Sep; 8(3):217-23. PubMed ID: 1958902
[TBL] [Abstract][Full Text] [Related]
11. Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease.
García-Malo MD; Corral J; González M; Solano C; González-Conejero R; Caballero MD; Pérez R; Moraleda JM; Vicente V
Transfusion; 2004 May; 44(5):771-6. PubMed ID: 15104661
[TBL] [Abstract][Full Text] [Related]
12. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
15. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
16. Recipient mHag-HA1 disparity and aGVHD in thalassemic-transplanted patients.
Nesci S; Buffi O; Iliescu A; Andreani M; Lucarelli G
Bone Marrow Transplant; 2003 Apr; 31(7):575-8. PubMed ID: 12692624
[TBL] [Abstract][Full Text] [Related]
17. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
18. [Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].
Shiobara S; Sato H; Furukawa T; Tsukada J; Yasue S; Takeda H; Togawa A; Taira M; Sakai Y; Aizawa Y; Nakao S
Rinsho Ketsueki; 2004 Jul; 45(7):518-23. PubMed ID: 15359910
[TBL] [Abstract][Full Text] [Related]
19. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
[TBL] [Abstract][Full Text] [Related]
20. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
